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While shorter instruments are more limited than longer measures,
they have obvious benefits for both research and policy in terms of
reduced burden and costs, and ease of interpretation.
A
frequently asked question by
clinical investigators is why they
should use a lengthy, multi-item
measurement scale to assess patients’
perceptions of their health, or quality of
life, when there is evidence that a
measure containing a single, global
question is likely to suffice.
Researchers may not wish to use
lengthy scales because their core ques-
tionnaires are already long, the patient
group of interest is ill or frail, they wish
to minimise the burden on the patient
and on the research team, or they
simply want a ‘‘snap shot’’ of a topic
rather than comprehensive coverage. In
such circumstances, single questions
have the obvious advantage of brevity,
of making fewer demands than multi-
item measures on respondents and
researchers. Single, global questions
have long been used in population
surveys to measure health status, qual-
ity of life (QoL), and health related
quality of life (HRQoL). The two most
popular single global health items are
self rated health status and self reported
limiting, longstanding illness.
SELF RATED HEALTH STATUS
The classic self rated health status item
consists of asking respondents to rate
their health as ‘‘excellent, good, fair, or
poor’’. Variations of this question have
been used in surveys worldwide.
Literature reviews on the conceptualisa-
tion and measurement of health pub-
lished by Rand in the USA1 2 and an
overview by Stewart and Ware3 reported
citations of the self rated health item as
early as early as the 1950s. For example,
a version appeared in a US study of
occupational retirement4 and in the US
Federal Civil Defense Administration
Survey, both in the 1950s.5 And a
question asking people to rate their
general health, followed by a broad
question about ill health (including
longstanding complaints) was also
included in the British government
Surveys of Sickness conducted between
1943 and 1952.6
Interest in using broad, subjective
health items dates from the mid-20th
century, and stemmed from the realisa-
tion that mortality was too insensitive to
use as a health care outcome indicator
in developed countries, that health has
physical, mental, social and spiritual
dimensions, and that patients’ perspec-
tives of their health and health out-
comes should be assessed. This was
given impetus by the World Health
Organisation’s abstract conceptualisa-
tion of health in its 1946 constitution
as ‘‘a state of complete physical, mental
and social wellbeing, and not merely the
absence of disease and infirmity’’,7 and
by subsequent investigations of lay
definitions of health, and variations in
illness behaviour. Survey researchers
found that single items measuring sub-
jective health and wellbeing did not
necessarily correlate with medical diag-
noses, but the former were held to have
greater validity in certain situations (for
example, when predicting help seeking
behaviour and health service use). Thus,
while in the first half of the 20th
century the focus of health measure-
ment was often limited to the presence
or absence of negative health states and
functioning, during the last half of the
century there was a shift in focus. There
was a trend in survey research towards
using the single global health status
question to integrate the different
dimensions of health emphasised in
the WHO definition. Consistent with
this changing emphasis, the British
government’s General Household
Survey (GHS) included a version of the
single health status item asking respon-
dents to rate their health from 1977
onwards, after deciding to broaden its
emphasis from use of services in relation
to chronic and acute illnesses, and check
lists of symptoms, and towards subjec-
tive perceptions of health.6 The question,
or a similar variant, was included in the
US National Health Interview Survey
(http://www.cdc.gov/nchs/nhis.htm) and
US National Health and Nutrition
Examination Survey (http://www.cdc.
gov/nchs/nhanes.htm). Most OECD
countries now conduct regular popula-
tion health interview surveys that
include this well known single item
(http://www.oech.org/publications). It
has also been used with satisfactory
levels of validity and reliability in the
developing world (for example,
Tanzania).8
The item was used in the Rand health
insurance experiment and medical out-
comes study,3 and now forms part of the
general health perceptions dimension in
the most widely used multi-item, multi-
dimensional health status measure of
all, which was developed from the initial
Rand measures—the short form-36 (SF-
36) (in both the Rand (http://www.
rand.org) and QualityMetric (http://
www.sf36.org) versions. In the late
1970s, to increase the question’s dis-
criminative ability, and because of the
operation of ‘‘social desirability’’ or
‘‘optimism’’ bias (leading to most
respondents to rate their health at the
positive end of the scale), the developers
of the SF-36 and others added a ‘‘very
good’’ category in between the ‘‘excel-
lent’’ and ‘‘good’’ response choices; the
short form-8 (developed from the SF-
36) also includes a ‘‘very poor’’ category
at the other end of the scale (http://
www.sf-36.org/demos/SF-8). The health
status item is popular in social gerontol-
ogy where the tradition has been to ask
respondents to rate their health in
relation to their age. This prevents older
respondents from assessing their health
with reference to younger age groups
and thereby perceiving it to be subopti-
mal.
A substantial body of international
research has reported the item to be
significantly and independently asso-
ciated with specific health problems,
use of health services, changes in func-
tional status, recovery from episodes of
ill health, mortality, and sociodemo-
graphic characteristics of respondents.9–17
It is judged to be appropriate for use in
population surveys. Investigators of the
MacArthur field study of successful
aging in the USA, for example, reported
that self rated health (poor/bad ratings
of health compared with excellent rat-
ings) was a strong and significant
predictor of mortality in the general
sample, as well as in controlled analyses
when the sample was divided into in
healthy and less healthy cohort sam-
ples.17 The question has been shown to
discriminate successfully between peo-
ple in different ethnic groups in Britain
(http://www.archive.officialdocuments.
co.uk/documents/doh/survey99/hse99),
Abbreviations: QoL, quality of life; HRQoL,
health related quality of life; GHS, General
Household Survey; VAS, visual analogue scale
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between indigenous and non-indigen-
ous Australians (http://www.abs.gov.
au/ausstats/abs@nsf), and between
Maori and other New Zealand sub-
groups (http://www.moh.govt.nz/moh.
nsf), although it is unknown whether
differences also reflect cultural varia-
tions in perceptions and reporting.
However, variations between surveys
and nations in the wording of the item,
and in the number of response cate-
gories, do limit comparative analyses
and interpretations. Analysis of data
from the Australian National Health
Survey has shown that it does have
some response instability when repeated
in the same questionnaire (before and
after other questions about health),
although this might also reflect the
biasing effect of question order.18 And
interpretation of the item at an indivi-
dual level varies, depending on the
referent being used by the respondent.
Some people refer to specific health
problems and others refer to general
physical functioning when replying to
the question.19 Other research using
anchoring vignettes (fixed descriptions
of each response choice level, to increase
consistency of respondents’ interpreta-
tions of them), has found that their use
provides a powerful tool for adjusting
for the influence of varying expectations
on self ratings of health.20 This can
improve comparison of results (for
example, older and younger people with
the same level of health might rank
themselves differently on a health status
scale because of varying expectations of
health and ability by age).
OTHER POPULAR SINGLE ITEMS
The second most popularly used single
item measures disability by asking
respondents if they have any ‘‘long-
standing illness, disability or infirmity’’.
Respondents who report positively are
usually asked if this limits their activ-
ities in any way. The British GHS has
included this item since 1972. Although
the prevalence of longstanding illness
has been shown to increase over the
past three decades of the GHS, the
pattern has fluctuated.21 Thus, while
the question has been shown to be
associated with health service use,
mortality, other indicators of function-
ing and health, age, socioeconomic
status, as well as self rated health,22
the question has posed an enigma for
researchers when comparing interna-
tional data and data over time. A review
of the use of the question (and varia-
tions of it) reported that it produced
estimates that were sensitive to question
wording and question order effects, to
the mode of data collection (for exam-
ple, interviewer compared with self
administered questionnaires), to the
survey process (for example, the collec-
tion of data by proxy) and the sponsor-
ship or contextual effects of the survey.23
It was concluded that estimates of
disability using such subjective single
item questions were less stable for
people who were above, than below,
state pension age; and unless surveys
that use the same single item instru-
ment follow identical survey procedures,
the interpretability of any evidence of
change over time is seriously compro-
mised. If single item questions are to be
used, then attention to clear, simple
wording at their design stage is
obviously essential.
The visual analogue scale (VAS) is
another frequently used single item
technique. The method uses lines, the
lengths of which are taken to denote the
continuum of some experience such as
tiredness, pain, nausea, or anxiety. The
lines are usually horizontal, 10 cm in
length, with stops (‘‘anchors’’) at right
angles to the line at both extremes,
representing the limits of the experience
being measured (for example, ‘‘severe
pain’’ to ‘‘no pain at all’’). The respon-
dent places a cross on the line to
indicate their state. A quality of life
VAS (often called a ‘‘QoL uniscale’’) is
in widespread use, in which the respon-
dent places a cross on a horizontal line
to indicate their quality of life during a
specified time period (anchored at each
end from ‘‘lowest quality’’ to ‘‘highest
quality’’). There are many references in
the literature to the high levels of
reliability, validity, and sensitivity of
this simple VAS technique, including
its ability to discriminate between
healthy and sick people, its sensitivity
to the stages of the disease progress, and
ability to predict mortality. Research
with cancer patients has also shown
that a single item QoL VAS has good to
excellent levels of reliability and validity
compared with multi-item measures.24
SINGLE COMPARED WITH MULTI-
ITEM MEASURES
Single item measures can be used
alongside multi-dimensional measures,
and are useful as broad summary rat-
ings of diverse aspects of respondents’
health, QoL, and HRQoL, especially
where respondents might have
improved on one domain (for example,
physical functioning) but not on
another (for example, mental function-
ing). They are also generally accepted as
useful in the assessment of health
transitions (for example, self assess-
ments of health as ‘‘better, same, or
worse’’). It has been proposed that
concepts such as health status, QoL
and HRQoL, when used as outcome
variables, are more appropriately mea-
sured with a global single item.25 This is
because multi-domain measures con-
found the dimensionality of these con-
cepts with the multiplicity of their
causal sources. Thus, in order that
predictor and component variables can
be separated, such concepts need to be
considered as unidimensional, but with
multiple causes. The unidimensional
indicator is then logically the dependent
variable in analyses, and the predictor
variables include the range of pertinent
multi-dimensional scale variables (for
example, social, psychological, func-
tional ability, etc).
While the single item question can
provide valuable information, it has the
advantage of simplicity, and can be
reliable and valid, it is at the expense
of detail. More information may be
required on different dimensions of
health, QoL or HRQoL, than a single
item can provide. Classic measurement
theory holds that single items are at a
relative disadvantage to multi-item
measures because more items produce
replies that are more consistent and less
prone to distortion from sociopsycholo-
gical biases, and this enables the ran-
dom error of the measure to be
cancelled out. Hence they are more
stable, reliable, and precise.
The careful development work on
health status batteries at Rand in the
USA has shown that a well constructed
multi-item scale (even with just 5–10
items) is more sensitive to changes in
patients’ condition over time than any
single item measure.26–28 In addition,
multi-item measures can provide a
complete profile of multidimensional
phenomenon, and can yield information
on changes within the individual
dimensions measured by the scale (for
example, physical functioning, psycho-
logical health), although at the cost of
increased burden and the risk of asking
irrelevant questions. Scales may be
preferred to single items because their
multiple items are suitable for statistical
calculations using summed and
weighted scores (for example, pain
might be given twice the weight of
mobility in the scale score, if it is judged
to be twice as important). On the other
hand, there is a body of literature in
psychology that shows there is little to
be gained by complex weightings over
simple summated scoring methods.29
PSYCHOMETRIC THEORY
Few of the initially developed measures
of health status or HRQoL were based
on established methods of scale con-
struction, although methods of scaling
had been developed in the early 20th
century (for example, Thurstone, Likert,
and Guttman techniques of scaling),
stemming, in particular, from the devel-
opment of occupational and intelligence
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testing, and the scientific principles of
measurement established by mathema-
tical psychologists during the mid-20th
century. These led to the establishment
of rigorous methods of psychometric
evaluation.30 31 Psychometric theory dic-
tates that when a concept cannot be
measured directly (for example, health
status, QoL, HRQoL), a series of ques-
tions that tap different aspects of the
same concept need to be asked. Items
can then be reduced, using specific
statistical methods, to form a scale of
the domain of interest, and the resulting
scale tested to ensure that it measures
the phenomenon of interest consistently
(reliability), that it is measuring what it
purports to measure (validity), and is
responsive to relevant changes over
time. The satisfaction of these condi-
tions is most probable when the result-
ing instrument contains several items to
measure the concept of interest to
permit testing for internal consistency
and to minimise random measurement
error. Although developed much earlier,
these standards for measurement and
scaling were little used in the health
field until the 1970s. Thereafter, during
the 1980s and 1990s, emerging patient
based health status and HRQoL mea-
sures were notable for their length,
sometimes containing well over 100
questions, their length being dictated
by the rigours of the theories and
methods of scaling and psychometrics.
More recently, burdened by the length
of such measures, investigators have
welcomed the development of briefer
measures. Hence there has been a
proliferation of increasingly short ver-
sions of existing measurement instru-
ments, and more efficient summary
measurement scales for use in the
burgeoning health outcomes sphere.28
One of the earliest and most extensive
applications of psychometric theory and
methods in the health measurement
field, began in the 1970s with the
refinement of health status measures
for Rand’s health insurance study and
medical outcomes study.3 One aim of
the latter was to construct the best
possible, and most efficient, scales for
measuring a wide range of functioning
and wellbeing. The Rand investigators
also realised that new standards of
measurement were needed because
while traditional testing showed that
longer measurement scales were more
reliable and valid than shorter scales,
they needed to consider respondent
burden and the costs of data collection
for their large scale studies. They saw
the need to compromise between tradi-
tionally defined standards of psycho-
metric excellence and newly identified
standards of feasibility and practicality;
and took as their starting point the
issues of which concepts should be
measured and how much measurement
would be enough for the intended
purpose. They attempted to achieve
reductions in respondent burden with-
out sacrificing measurement precision
below a critical level, and their achieve-
ments are apparent when contrasting
the number of items in the measuring
instruments used in their health insur-
ance experiment with the smaller num-
ber of items for their later medical
outcomes study (for example, 25 items
compared with 10 items to measure
physical functioning). These methodo-
logical developments have continued,
and probably the most well known
example of these is the development of
the short form-12 (12 items) and the
short form-8, both derived from the
short form-36 health status question-
naire, as well as the development of
summary measures of physical and
mental health (see http://www.sf-36.
org) and http://www.rand.org).
While the shorter versions of these
short form scales are inevitably less
sensitive than the full versions, their
careful and thorough psychometric
development and calibration, based on
the most powerful items from the
parent instruments, has led to their
retaining a high degree of accuracy,
and hence their increasing popularity
in research on clinical outcomes and
population health. The longer SF-36
contains several questions to measure
each of the eight dimensions that it
includes (physical and social function-
ing, physical and emotional role limita-
tions, mental health, energy/vitality,
pain, and general health perceptions),
but the SF-8 derived from it contains
just one single item to measure each of
these same eight domains. Moreover,
the health perceptions item is a varia-
tion of the long used health status
question: ‘‘Overall, how would you rate
your health in the past four weeks?
Excellent, very good, good, fair, poor, or
very poor?’’ Thus the robustness of this
item, which has been used, with small
variations, as a single item measure of
health status in population surveys for
over half a century, has at last achieved
authoritative acknowledgement.
In conclusion, with the use of more
advanced statistical and psychometric
techniques, and with awareness of the
need to balance psychometric accept-
ability with practicality, scale developers
have responded positively to the fre-
quently asked question: ‘‘If one question
works, why ask several?’’ Investigators
now have an evidence base to guide
their selection of longer or shorter
multi-dimensional scales and/or single
item measures, depending on the pur-
pose and needs of the study. While
shorter instruments are more limited
than longer measures, they have
obvious benefits for both research and
policy in terms of reduced burden and
costs, and ease of interpretation.
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Epidemiologists face a permanent challenge towards improving
the design, analysis, interpretation, and reporting of
observational and evaluative studies.
B
ased on the analysis of a sample of
articles that reported the results
obtained in observational epide-
miological studies published in major
journals, Pocock et al1 raised ‘‘serious
concerns regarding inadequacies in the ana-
lysis and reporting of epidemiological pub-
lications’’, thereby intensifying the
outcry regarding the low quality of these
papers and the need for guidelines
regulating their publication.2 Moreover,
epidemiological studies that fail to
identify important associations or in
which associations that were reported
are later shown in effect not to exist
abound in the literature. These errors
often result in serious consequences, for
example, when they involve the evalua-
tion of interventions that cause adverse
effects on human health. One recent
case refers to the association between
hormone replacement therapy (HRT)
and cardiovascular disease (CVD), in
which various observational studies
systematically pointed in one single
and erroneous direction—to the protec-
tive role of HRT in the occurrence of
CVD.3 Surprisingly, two recently pub-
lished randomised controlled trials
(RCT) showed completely contrasting
results—a harmful effect of HRT on the
occurrence of CVD.4 5 There is no doubt
that this ‘‘mistake’’ has had serious
implications in women’s health as for
several years millions of women world-
wide were prescribed with HRT without
doctors and patients being aware of the
harm it could cause.
As epidemiological knowledge is pre-
dominantly built on results obtained
from observational studies, the implica-
tions of wrong findings originating from
these studies have been constraining
both for epidemiologists and for those
who make use of epidemiological
knowledge. Consequently, demands are
quite rightly being made for reconsi-
deration of issues concerning the rela-
tion between the outcomes of
experimental and observational epide-
miological studies. Discussions have
covered conceptual and methodological
aspects and more pragmatically the
implications of the two different
approaches in medicine and public
health.
With respect to the evaluation of
medical technologies (medicines, vac-
cines, etc), there is a general consensus
that RCTs are the gold reference stan-
dard; however, this consensus is com-
monly extrapolated to the idea that, just
as medical interventions, public health
ones not submitted to randomised trials
are unworthy of consideration as such,
and it is recommended: ‘‘to reject the
scientific double standard of what constitutes
acceptable evidence of efficacy for clinical
versus public health interventions’’.6
This question, despite all its impor-
tance for public health practices, has
received sparse attention from epide-
miologists and public health practi-
tioners. While the modern practice of
medicine is centred on interventions
developed as a result of biomedical
research, the same does not occur in
public health. The central aim of any
public health intervention must be to
modify the health of populations, even-
tually by reducing the harmful effects of
morbid occurrences but principally by
reducing the occurrence rates of these
events—that is, their incidences. With
respect to the goal of reducing inci-
dence, biomedicine so far has made
available to public health a set of
interventions that, although relevant,
are limited to only a few of the problems
tormenting the health of the human
populations. Vaccines are perhaps the
most important biomedical technology
offered to the public health intervention
arsenal in present times; however, they
are restricted to the infectious diseases
and to just a few of them. The great
majority of potential public health inter-
ventions whether behavioural, environ-
mental, or social that could have a
modifying effect on the population
health in terms of a reduction in the
incidence of specific or unspecific mor-
bid events are outside the sphere of
biomedicine.
Another no less important aspect is
that public health interventions, even if
applicable in individuals, need to be
applied over populations to be effective.
To achieve their aims they have to be
organised into programmes running in
the frame of established health policies
and at the same time to have several
other characteristics apart from efficacy.
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For instance, for a vaccine to be used on
an immunisation programme, besides
efficacy, several other related character-
istics (costs, logistics, secondary effects,
adverse effects, cross immunity, etc)
need to be established. These character-
istics taken together comprise what is
referred to as effectiveness.7 Effec-
tiveness is therefore a measure synthesis
of a pool of elements (including the
vaccine efficacy) and is best estimated
in evaluative studies (eventually RCTs)
in which the unit of intervention and
analysis are populations and not indivi-
duals.8 In summary, as far as public
health is concerned, studies evaluating a
immunisation programme effectiveness
are just as important as those centred
on evaluating the efficacy of the vaccine
used in the same programme. As a
consequence, an immunisation pro-
gramme using a highly efficacious vac-
cine may fail to be recommended to a
population, because of a not so high or
even low effectiveness.
In situations in which the interven-
tions do not involve biomedical technol-
ogies, as is the case of most of the public
health interventions, it is very difficult
to evaluate the real efficacy of such
interventions. In many cases the inter-
vention only exists as a programme or
a policy. In such cases, the only resource
left is to estimate effectiveness as
there is no efficacy to be estimated.
Although sometimes possible, it is
operationally difficult to carry out ran-
domised studies to estimate the effec-
tiveness of such interventions and the
only remaining possibility in many
situations being observational studies
or non-randomised quasi-experiments.9
This perspective in evaluating public
health interventions brings us closer
to the traditions of evaluating social
interventions programmes and policies
in general, in which it is possible, while
not always feasible, to use randomised
designs instead of the non-randomised
quasi-experiments or observational
alternatives.10
The requirement to establish the
efficacy of biomedical technologies by
means of RCTs was a great achievement
in terms of offering more effective and
safe treatment options to the popula-
tion. However, the automatic transferal
of this principle to public health is
based on the belief that public health
is merely an extension of medicine
and consequently that their interven-
tions mean biomedical interventions
applied to populations. Sustaining this
false assertive and believing that the
evaluative standard of the public health
interventions always are RCTs, would
make it unfeasible for public health to
propose interventions in areas such
as the environment, education, beha-
viour, and principally social interven-
tions such as those concerning health
inequalities.11
For epidemiologists and others
involved in the evaluation of the impact
of public health interventions these
misunderstandings and just criticisms
must be interpreted as renewed oppor-
tunities to reaffirm the permanent
challenge towards improving the design,
analysis, interpretation, and report of
the observational or quasi-experimental
evaluative studies.
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A
gerbo reports a nested case-con-
trol study of all (n=9011) Danish
midlife suicides (25–60 years of
age) 1982–97.1 He investigated sex
specific midlife suicide risks associated
with spousal psychiatric admission,
spouse or child bereavement by suicide
or other causes of death, and several
sociodemographic factors. There is a
wealth of original findings from this
impressive population based register
study. Particularly, increased suicide
risks were seen after spousal psychiatric
admission or spousal or child death,
especially after spousal suicide. Several
points of criticism regarding certain
study premises and the interpretation
of study findings are discussed here. In
what follows, I will focus on five points:
firstly, the age range restriction; sec-
ondly, the psychiatric admission
criterion; thirdly, the environmental
interpretations of certain findings;
fourthly, the implications of assortative
mating; and fifthly, the evidence for sex
specific suicide risks. An attempt is
made to place this study’s findings in
the context of present information
on the epidemiology of suicide.
Furthermore, brief comments on the
relevance of the study findings and on
new research or methodology needed to
overcome the present limitation of the
knowledge in this area are given.
Firstly, the range restriction in age
(25–60 years) clearly restricts the gen-
eralisability of this study: it does not
capture total (lifetime) suicide mortal-
ity. Internationally, in most Western
industrialised nations, there is a notice-
able positive age relation of suicide risk
that furthermore is more pronounced
for men than for women. Consider the
Danish suicide rates of the elderly
population (aged 65 years or over), as
available from the European Health for
All database (http:/www.euro.who.int/
hfadb): during the study period (1982–
97), yearly male suicide rates were up to
71.2 and never below 48.7 (median rate:
57.3), and female rates were up to 36.6
and never below 17.2 (median rate:
30.8). Although Agerbo’s study is popu-
lation based, it misses many suicides
that occurred in this population.
General conclusions might thus be
unwarranted. Across most Western
industrialised nations, most suicides
occur well beyond midlife and this
pattern has become more pronounced
over the past decades, especially so for
men.2 Therefore, research is needed that
takes into account the particular age
pattern in the prevalence of suicide by
analysing lifetime suicide mortality.
Secondly, a psychiatric admission
criterion was used as a proxy variable
for psychiatric disorders. This certainly
constitutes a too restrictive criterion, as
only the most severe cases are included.
Agerbo emphasises that admission to all
psychiatric inpatient facilities is regis-
tered and that there are no private
psychiatric hospitals in Denmark, but it
is well known and, in fact, a truism that
most psychiatric illness episodes do not
lead to admission to inpatient facilities,
but rather are seen by general practi-
tioners, practising psychiatrists, or out-
patient facilities only. This further
compromises the generalisability of this
study’s findings. Research designs from
field epidemiology, in the spirit of
catchment area studies, would be
needed to gain more clarity on this
point. Crisis intervention centres and
related facilities often maintain large
consultation databases that consider-
ably date back. Using more appropriate
proxy variables or indicators for psy-
chiatric disorders than the psychiatric
admission criterion, such files could be
screened for adverse mental health
effects (including suicidality) of spousal
psychiatric illness episodes.
Thirdly, although genetic evidence for
suicide susceptibility is mentioned by
Agerbo, an environmental stance in the
interpretation of findings is obvious.
Specifically, it is asserted that specific
genes associated with suicide are yet to
be identified. However, converging evi-
dence from clinical, family, twin, and
adoption studies suggest a non-trivial
role for genetic factors in the predis-
position to suicidal behaviour,3–6 which
may further differ between populations
and thus may also contribute to cross
national differences in suicide rates.7 8
Most recently, several molecular genetic
studies reported that polymorphisms of
the tryptophan hydroxylase gene are
related to suicidal behaviour, and these
findings have been summarised and
confirmed in meta-analyses.9 10 Further
molecular genetic studies of suicide
attempters or relatives of suicide vic-
tims, along with twin, family, and half
sibling study designs, would be helpful
to disentangle the relative contributions
of genetic, non-shared, and shared
environmental contributions of suicid-
ality. The full relevance of the current
evidence for heritability of suicidality
becomes clear in connection with the
next point.
Fourthly, assortative mating on
human behavioural traits is the rule.
Although the assortative mating princi-
ple is mentioned in Agerbo’s study, its
far reaching implications, given wide-
spread trait heritability, seem under-
valued therein. Almost everything under
the sun is heritable, and it has been
stated that non-zero heritability is
something like the ‘‘first law’’ of beha-
viour genetics and that zero heritability
no longer is an interesting null hypoth-
esis.11 Among other evidence, spousal
correlations of up to 0.4012 13 on moder-
ately heritable personality traits14 have
been reported. Agerbo even cites a study
reporting that patients with schizophre-
nia might find a partner during psy-
chiatric admission. But possible
assortative mating effects are too
quickly downplayed on two grounds:
first of all, because suicide risk was not
further influenced when both partners
had a psychiatric admission (the proble-
matic nature of this criterion was
emphasised above); and then, because
of sex differences in specific suicide
risks (the extent of these is discussed
below). At least in a retrospective fash-
ion, the extent of assortative mating
effects on suicidal traits in the general
population could be investigated in the
course of psychological autopsy studies
of suicide victims and their surviving
partners. Available evidence regarding
the extent of assortative mating among
psychiatric patients is not extensive, so
this topic definitely is worth examining
further.
Fifthly, there is little evidence for sex
differences in specific suicide risks in
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this study, thus invalidating Agerbo’s
argument that these would suggest that
assortative mating effects are not impor-
tant here, and, by extension, that the
results are more probably attributable to
environmental than to genetic suscept-
ibility factors. The sex specific analyses
suffer from low statistical power
because of sparse data and from possible
misclassifications, and thus could be
chance results. Agerbo found that a
recent (past two years) spousal psychia-
tric admission increased the suicide risk
more in women than in men (based on
48 male compared with 25 female cases
only). Conversely, recent spousal suicide
increased suicide risk more in men than
in women (16 compared with 12 cases),
as did recent spousal death by other
causes (37 compared with 17 cases).
This truly constitutes a complicated
pattern of related findings that seems
difficult to interpret in a parsimonious
manner. I am not aware of any sound
and replicated evidence from research
on suicide survivors15 16 that would
bolster these findings, which further-
more, importantly so, are all statistically
not significant. Agerbo further concedes
that the data might contain cases of
dyadic deaths (homicide-suicide), with
typically male perpetrators. While it is
true that dyadic deaths are infrequent,
such misclassifications alone could
account for the third finding above.
The above set of findings therefore is
in need of clarification through replica-
tion in other populations. Additionally,
it would be worthwhile to address the
extent of misclassifications attributable
to dyadic deaths directly with record
linkage studies that use forensic regis-
ters. However, given the rarity of such
cases, deepened knowledge on them
would probably be of uncertain practical
utility for general prevention and inter-
vention strategies.
To summarise, this study leaves some
important questions unanswered.
Particularly, it may well be that assorta-
tive mating on heritable traits, such as
personality variants, psychiatric disor-
ders, and suicidality itself, contribute to
the observed increased suicide risk after
spousal suicide or psychiatric admission.
This alternative hypothesis could be
investigated and tested through conve-
nient combinations of the research
designs proposed above.
The final note here concerns the use
of the term ‘‘gender’’ in this study. I
think it would be more appropriately
termed being a sex specific study rather
than a gender specific study.17 18 The
meaning of sex (male, female) is biolo-
gical, referring to the biological distinc-
tion of males and females, whereas the
meaning of gender is cultural, referring
to men and women as social groups, and
including more than biological maleness
compared with femaleness—such as
identity, norms, roles, personal and
social status—which human character-
istics undoubtedly are as important in
suicidology than elsewhere.
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